EndoGene.Bio
PrivateLast Round
Grant
Jun 15, 2026
Total Funding Raised
$1.95M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
EndoGene.Bio is a biotechnology company that is developing a precision medicine platform using menstrual blood to create non-invasive diagnostics and tools for patient stratification for uterine diseases like endometriosis.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Precision Medicine, Drug Discovery, Clinical Trials, Medical AI
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
EndoGene.Bio Comparables
Compare EndoGene.Bio with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| NextGen Jane | 79% | |
| Endodiag | 78% | |
| DotLab | 78% |
EndoGene.Bio Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Jun 15, 2026 | ||||
| Seed | Feb 1, 2025 |
Key People
Founding team and executive leadership
EndoGene.Bio Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Genopole | Seed |
| Hello Tomorrow | Grant |
| Entrepreneurs First | Seed, Accelerator |
| Bpifrance | Seed |
| Frontline Ventures | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 15, 2026
$107K grant received from Hello Tomorrow.
- Jan 8, 2026
Monthly visitors grew 1014% MoM, from 81 to 902.
EndoGene.Bio Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about EndoGene.Bio's valuation, stock price, and market status.
Is EndoGene.Bio a public or private company?
EndoGene.Bio is a private company.
What is the current stock price of EndoGene.Bio?
EndoGene.Bio is a private company with no public stock price. No recent secondary market data is available.
How much is EndoGene.Bio worth (valuation)?
Valuation information for EndoGene.Bio is not publicly available.
Can I buy EndoGene.Bio stock?
EndoGene.Bio shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was EndoGene.Bio's last funding round?
EndoGene.Bio's most recent funding round was Grant on June 15, 2026.
Who are the main investors in EndoGene.Bio?
Key investors in EndoGene.Bio include Entrepreneurs First.
Will EndoGene.Bio IPO soon?
No public IPO plans have been announced for EndoGene.Bio.
How can I track EndoGene.Bio secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor EndoGene.Bio's secondary market activity and sign up for updates.